Published in Clin Exp Allergy on June 01, 2000
Analysing the eosinophil cationic protein--a clue to the function of the eosinophil granulocyte. Respir Res (2011) 1.07
CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules. FASEB J (2012) 0.89
Proline-rich tyrosine kinase 2 regulates spreading and migration of eosinophils after beta2-integrin adhesion. Am J Respir Cell Mol Biol (2008) 0.89
PI3K, ERK, p38 MAPK and integrins regulate CCR3-mediated secretion of mouse and human eosinophil-associated RNases. Allergy (2013) 0.80
Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia. PLoS One (2015) 0.79
Matrix proteins and eosinophil mediator release. Clin Exp Allergy (2000) 0.75
Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56
Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology (1995) 1.30
Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24
Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg (1996) 1.24
Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21
Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res (1999) 1.16
Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11
Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol (1996) 1.09
Effect of hyaluronic acid on phagocytosis of opsonized latex particles. Scand J Immunol (1980) 1.07
Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy. Am J Reprod Immunol (1996) 1.05
Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol (1991) 1.03
Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment. Br J Cancer (1996) 1.03
Therapist-assisted versus self-help relaxation treatment of chronic headaches in adolescents: a school-based intervention. J Child Psychol Psychiatry (1987) 1.01
Improving the efficacy of cancer immunotherapy. Eur J Cancer (2009) 1.01
Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol (1999) 1.01
On the presence within tumours of clones that differ in sensitivity to cytostatic drugs. Acta Pathol Microbiol Scand A (1974) 1.01
Kinetic studies of neutrophil phagocytosis. V. studies on the co-operation between the Fc and C3b receptors. Immunology (1982) 0.99
Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol (1996) 0.98
Eosinophil activation in allergic disease. Int Arch Allergy Appl Immunol (1987) 0.98
Leucocyte adhesion protein deficiency in Irish setter dogs. Vet Immunol Immunopathol (1992) 0.95
Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables. Eur Respir J (1988) 0.94
Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol (1996) 0.94
The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. J Immunol (1985) 0.93
Effect of microspheres in intra-arterial chemotherapy. A study of arterio-venous shunting and passage of a labelled marker. Med Oncol Tumor Pharmacother (1987) 0.93
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases. Br J Cancer (2003) 0.92
Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity. Inflammation (1989) 0.90
A new injection portal for brachially inserted central venous catheter. A multicenter study. Med Oncol Tumor Pharmacother (1990) 0.90
Intrathecal sufentanil compared with epidural bupivacaine analgesia in labour. Eur J Anaesthesiol (1997) 0.90
Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin. J Urol (1996) 0.89
CD64 (Fcgamma receptor I) cell surface expression on maturing neutrophils from preterm and term newborn infants. Acta Paediatr (2005) 0.89
Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol (1992) 0.89
Human mammary carcinoma studied for hormone responsiveness in short term incubations. Acta Chir Scand (1974) 0.89
Continuous treatment of non-Hodgkin's malignant lymphoma with prednimustine (Leo 1031). Oncology (1978) 0.88
Cell clones with different sensitivity to cytostatic drugs in methylcholanthrene-induced mouse sarcomas. Acta Pathol Microbiol Scand A (1974) 0.87
Current understanding of the role of the eosinophil granulocyte in asthma. Clin Exp Allergy (1991) 0.87
Serum-levels of lactoferrin, lysozyme and myeloperoxidase in normal, infection-prone and leukemic children. Clin Chim Acta (1984) 0.86
Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol (1991) 0.86
Enhanced expression of integrins and CD66b on peripheral blood neutrophils and eosinophils in patients with rheumatoid arthritis, and the effect of glucocorticoids. Scand J Immunol (1999) 0.86
Effect of IFN-alpha on tumor-infiltrating mononuclear cells and regressive changes in metastatic malignant melanoma. J Interferon Cytokine Res (1998) 0.85
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes. Br J Cancer (2001) 0.84
Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis. Arch Dermatol Res (1985) 0.84
Effects of in vivo administration of G-CSF on neutrophil functions in healthy volunteers. Eur J Haematol (1997) 0.84
Increased nitric oxide elimination from the airways after smoking cessation. Clin Sci (Lond) (2002) 0.83
A method to study apoptosis in eosinophils by flow cytometry. J Immunol Methods (2000) 0.83
C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes. Scand J Immunol (2006) 0.83
Heterogeneity of human adenocarcinomas of the colon and the stomach as regards sensitivity to cytostatic drugs. Neoplasma (1975) 0.83
Regulation of human eosinophil migration across lung epithelial monolayers by distinct calcium signaling mechanisms in the two cell types. J Immunol (1999) 0.83
Expression of ICAM-1 during IFN-alpha-based treatment of metastatic malignant melanoma: relation to tumor-infiltrating mononuclear cells and regressive tumor changes. J Interferon Cytokine Res (1999) 0.82
Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy (1994) 0.82
A liveborn triploid infant. Acta Paediatr Scand (1974) 0.82
The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system. Ann N Y Acad Sci (1993) 0.82
Kinetic studies of phagocytosis. IV. Cellular defects and humoral inhibition as causes of impaired neutrophil phagocytosis in sarcoidosis. Clin Exp Immunol (1982) 0.82
Human alveolar macrophages from smokers have an impaired capacity to secrete LTB4 but not other chemotactic factors. Eur J Respir Dis (1987) 0.81
Serum-mediated stimulation and inhibition of neutrophil locomotion in sarcoidosis. Eur J Respir Dis (1984) 0.81
Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol. J Allergy Clin Immunol (1992) 0.81
The molecular basis of the hyaluronic acid-mediated stimulation of granulocyte function. J Immunol (1987) 0.81
Defects in polymorphonuclear neutrophil function and susceptibility to infection in children. Scand J Clin Lab Invest (1986) 0.81
Neutrophil function in infection-prone children. Arch Dis Child (1980) 0.81
Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapy. Int Arch Allergy Appl Immunol (1987) 0.81
The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber. Scand J Immunol (1984) 0.81
Degranulation of primary and secondary granules in adherent human neutrophils. Scand J Immunol (2002) 0.81
Cytokine production in peripheral blood cells during and outside the pollen season in birch-allergic patients and non-allergic controls. Clin Exp Allergy (2004) 0.81
On down-regulation of the immune response to metastatic malignant melanoma. Cancer Immunol Immunother (1999) 0.80
Expression of adhesion and Fcgamma-receptors on canine blood eosinophils and neutrophils studied by anti-human monoclonal antibodies. Vet Immunol Immunopathol (1998) 0.80
Lymphocyte subsets and mitogen stimulation of blood lymphocytes in preeclampsia. Am J Reprod Immunol (1999) 0.80
Partial characterization and identification of chemokinetic factors in serum. Scand J Immunol (1983) 0.79
Subcutaneous administration of hyaluronan reduces the number of infectious exacerbations in patients with chronic bronchitis. Am J Respir Crit Care Med (1996) 0.79
Eosinophil cationic protein is stored in, but not produced by, peripheral blood neutrophils. Clin Exp Allergy (2002) 0.79
An in vitro study of cytostatic drug effect on the drug effect on the DNA synthesis in methylcholanthrene induced mouse sarcomas. Correlation between in vitro results and the response in vivo. Acta Pathol Microbiol Scand A (1974) 0.79
Hyaluronic acid stimulates neutrophil function in vitro and in vivo. A review of experimental results and a presentation of a preliminary clinical trial. Scand J Infect Dis Suppl (1980) 0.79
The effect of prednisolone on canine neutrophil function: in vivo and in vitro studies. Acta Vet Scand (1998) 0.79
Kinetic studies of phagocytosis. II. The serum-independent uptake of IgG-coated particles by polymorphonuclear leukocytes from uremic patients on regular dialysis treatment. J Lab Clin Med (1979) 0.79
Granulocyte function in dogs experimentally infected with a Swedish granulocytic Ehrlichia species. Vet Immunol Immunopathol (1999) 0.78
Polymorphonuclear neutrophil function and infections following splenectomy in childhood. Scand J Haematol (1986) 0.78
Interleukin-2 inhibits eosinophil migration but is counteracted by IL-5 priming. Clin Exp Allergy (2001) 0.78
An in vitro study of the effect of cytostatic drugs on DNA synthesis in methylcholanthrene induced mouse sarcomas and in rat Walker 256 tumours. Acta Pathol Microbiol Scand A (1973) 0.78
Differential expression of the C5a receptor and complement receptors 1 and 3 after LPS stimulation of neutrophils and monocytes. Scand J Immunol (2004) 0.78
Canine neutrophil adhesion proteins and Fc-receptors in healthy dogs and dogs with adhesion protein deficiency, as studied by flow cytometry. Vet Immunol Immunopathol (1993) 0.78
Exercise-induced asthma and the generation of neutrophil chemotactic activity. J Allergy Clin Immunol (1990) 0.78
Monocytes, but not macrophages, produce the eosinophil cationic protein. APMIS (2001) 0.78
On heterogeneity of non-Hodgkin's lymphomas as regards sensitivity to cytostatic drugs. An in vitro study. Eur J Cancer (1980) 0.77
The chemotactic response of granulocytes to the low molecular weight chemoattractants f-MLP, C5f, and LTB4 is dependent on chemokinetic factors. J Leukoc Biol (1985) 0.77
Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera. Immunology (1982) 0.77
Treatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheres. Br J Surg (1994) 0.77
Neutrophil phagocytosis in sarcoidosis. Reduced C3b receptor-mediated phagocytosis in active and silent sarcoidosis. Clin Exp Immunol (1985) 0.77
Effect of interferon-alpha on the expression of tumour necrosis factor-alpha by metastatic malignant melanoma in vivo. Melanoma Res (1997) 0.77
Identification of a serum-derived promotor of granulocyte granule secretion: study on a patient with chronic pruritus. Immunology (1982) 0.77
Effect of starch microspheres on the passage of labelled erythrocytes and a low molecular weight marker through the liver. Acta Oncol (1987) 0.76
Heat-labile neutrophil chemotactic activity in subjects with asthma after allergen inhalation: relation to the late asthmatic reaction and effects of asthma medication. J Allergy Clin Immunol (1987) 0.76
Effect of unilateral nucleus basalis lesion on cortical and striatal acetylcholine and dopamine release monitored in vivo with microdialysis. Neurosci Lett (1990) 0.76
Enhanced neutrophil and eosinophil adhesion in patients with primary Sjögren's syndrome. Clin Exp Rheumatol (1998) 0.76
Simultaneous analysis of eosinophil and neutrophil adhesion to plasma and tissue fibronectin, fibrinogen, and albumin. J Immunol Methods (1999) 0.76
Increased chemokinetic and chemotactic responses of eosinophils in asthmatic patients. Allergy (1991) 0.76
[Hyperthyroxinemia--results and conclusions are not in accordance]. Lakartidningen (1995) 0.75
Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis. Arch Dermatol Res (1987) 0.75
Indices of inflammatory activity in CB and COAD. Phagocyte secretion and chemotaxis. Agents Actions Suppl (1990) 0.75
Intra-arterial mitomycin C treatment of unresectable liver tumours. Preliminary results on the effect of degradable starch microspheres. Acta Oncol (1987) 0.75
Defective C3b receptor-mediated phagocytosis of neutrophils in patients with primary biliary cirrhosis. Scand J Gastroenterol (1987) 0.75